Science Explorer Back to mapMap
Discussion
Researcher · University of New Mexico · United States

Mark B. Carter

Mark B. Carter publishes mostly in Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging, on topics such as Monoclonal and Polyclonal Antibodies Research, RNA Interference and Gene Delivery and PI3K/AKT/mTOR signaling in cancer.

OpenAlex
World rank
#6,596,727
of 7,710,434 ranked researchers
Rank in United States
#1,536,194
of 1,627,098
Works
82
Citations
1.8k
Citations per work
22.2
h-index
14
i10-index 15Top 55% in Molecular Biology
Mark B. Carter

What does Mark B. Carter research?

Mark B. Carter's work is mostly in Biochemistry, Genetics and Molecular Biology (19%), Medicine (10%), Chemistry (8%).

Everything else: 45 works · 54.4% of their workLife Sciences: 16 works · 19.2% of their workBiochemistry, Genetics and Molecular Biology: 16 works · 19.2% of their workMolecular Biology: 16 works · 19.2% of their workPhysical Sciences: 11 works · 13.2% of their workChemistry: 6 works · 7.8% of their workOrganic Chemistry: 6 works · 7.8% of their workMaterials Science: 4 works · 5.4% of their workMaterials Chemistry: 4 works · 5.4% of their workHealth Sciences: 8 works · 9.6% of their workMedicine: 8 works · 9.6% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 5.4% of their workOncology: 3 works · 4.2% of their workSocial Sciences: 3 works · 3.6% of their workDecision Sciences: 3 works · 3.6% of their workStatistics, Probability and Uncertainty: 3 works · 3.6% of their workTHEIR WORKMark B. Carter82works
Life Sciences19%Physical Sciences13%Health Sciences10%Social Sciences4%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else4554.4%
    1. Biochemistry, Genetics and Molecular Biology1619.2%
    1. Chemistry67.8%
    2. Materials Science45.4%
    1. Medicine89.6%
    1. Decision Sciences33.6%
  1. 1Molecular Biology19% of their works
  2. 2Organic Chemistry8% of their works
  3. 3Radiology, Nuclear Medicine and Imaging5% of their works
  4. 4Materials Chemistry5% of their works
  5. 5Oncology4% of their works
  6. 6Statistics, Probability and Uncertainty4% of their works

Research topics

Which keywords describe Mark B. Carter's research?

The keywords of their largest research topics: Fc Receptors, Therapeutic Antibodies, Enthalpies, mTOR, RNA Interference, Signaling, siRNA Delivery and Vaporization.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Fc Receptors51 topic
  2. Therapeutic Antibodies51 topic
  3. Enthalpies41 topic
  4. RNA Interference41 topic
  5. Signaling41 topic
  6. Vaporization41 topic
  7. mTOR41 topic
  8. siRNA Delivery41 topic
  9. Chemistry Education31 topic
  10. Ion-Selective Electrodes31 topic
  11. Laboratory Techniques31 topic
  12. Microfluidics31 topic
  13. Optical Sensors31 topic
  14. Particle Separation31 topic
  15. Single-Cell31 topic
  16. Transcriptomics31 topic

Where does Mark B. Carter work?

Mark B. Carter's main affiliation in the publication record is University of New Mexico, United States.

How many publications and citations does Mark B. Carter have?

OpenAlex counts 82 works and 1,817 citations for Mark B. Carter, an h-index of 14, ranking #6,596,727 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark B. Carter. Posts are plain text and can be reported.